Aptevo Therapeutics Inc (NASDAQ: APVO) on Friday, plunged -6.25% from the previous trading day, before settling in for the closing price of $1.6. Within the past 52 weeks, APVO’s price has moved between $1.32 and $381.10.
A company in the Healthcare sector has jumped its sales by 80.96% annually for the last half of the decade. The company achieved an average annual earnings per share of 99.19%. With a float of $3.29 million, this company’s outstanding shares have now reached $3.29 million.
Aptevo Therapeutics Inc (APVO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Aptevo Therapeutics Inc is 8.67%, while institutional ownership is 31.39%.
Aptevo Therapeutics Inc (APVO) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -355.2 earnings per share (EPS) for the period topping the consensus outlook (set at -421.8) by 66.6. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.9 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 99.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 83.99% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Aptevo Therapeutics Inc (APVO) is currently performing well based on its current performance indicators. A quick ratio of 2.27 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -540.69, a number that is poised to hit -2.09 in the next quarter and is forecasted to reach -7.42 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Let’s dig in a bit further. During the last 5-days, its volume was 2.28 million. That was inferior than the volume of 2.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.06%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 1.38%, which indicates a significant decrease from 12.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2678 in the past 14 days, which was lower than the 0.4862 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0788, while its 200-day Moving Average is $33.6818. However, in the short run, Aptevo Therapeutics Inc’s stock first resistance to watch stands at $1.5767. Second resistance stands at $1.6533. The third major resistance level sits at $1.6967. If the price goes on to break the first support level at $1.4567, it is likely to go to the next support level at $1.4133. The third support level lies at $1.3367 if the price breaches the second support level.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
Market capitalization of the company is 4.93 million based on 3,288K outstanding shares. Right now, sales total 0 K and income totals -24,130 K. The company made 0 K in profit during its latest quarter, and -6,200 K in sales during its previous quarter.
